Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickshVIVO Regulatory News (HVO)

Share Price Information for hVIVO (HVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.80
Bid: 27.50
Ask: 28.10
Change: 0.05 (0.18%)
Spread: 0.60 (2.182%)
Open: 27.95
High: 28.00
Low: 28.00
Prev. Close: 27.95
HVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Major Interest in Shares

27 Oct 2016 07:00

RNS Number : 5687N
hVIVO plc
27 October 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

hVIVO Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

No

3. Full name of person(s) subject to thenotification obligation: iii

Invesco Limited

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

24 October 2016

6. Date on which issuer notified:

26 October 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

27%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

Ordinary 5p

GB00B6ZM0X53

20,993,769

20,993,769

21,249,382

27.20%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

21,249,382

27.20%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Invesco Asset Management Limited - 21,249,382

Proxy Voting:

10. Name of the proxy holder:

Invesco Limited

 

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

14. Contact name:

Philippa Holmes

15. Contact telephone number:

01491 417 447

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAFEKASAKFAF
Date   Source Headline
17th Jul 20187:00 amRNSNotification of Major Holdings
13th Jul 20183:35 pmRNSNotification of Major Holdings
10th Jul 20187:00 amRNSNotification of Major Holdings
9th Jul 20182:37 pmRNSDirectorate Change
6th Jul 20184:40 pmRNSSecond Price Monitoring Extn
6th Jul 20184:35 pmRNSPrice Monitoring Extension
6th Jul 20187:00 amRNSNotification of Major Interest in Shares
5th Jul 20183:00 pmRNSDirector's Dealings
5th Jul 201811:05 amRNSSecond Price Monitoring Extn
5th Jul 201811:00 amRNSPrice Monitoring Extension
5th Jul 20189:05 amRNSSecond Price Monitoring Extn
5th Jul 20189:00 amRNSPrice Monitoring Extension
5th Jul 20187:00 amRNSNotification of Major Interest in Shares
3rd Jul 20187:00 amRNSNotification of Major Interest in Shares
2nd Jul 20187:00 amRNSNotification of Major Interest in Shares
28th Jun 20187:00 amRNSNotification of Major Interest in Shares
27th Jun 20187:00 amRNSNotification of Major Interest in Shares
22nd Jun 20187:00 amRNSNotification of Major Interest in Shares
21st Jun 20187:00 amRNSNotification of Major Interest in Shares
20th Jun 20182:00 pmRNSNotification of Major Interest in Shares
20th Jun 201811:05 amRNSSecond Price Monitoring Extn
20th Jun 201811:00 amRNSPrice Monitoring Extension
20th Jun 20187:00 amRNSNotification of Major Interest in Shares
19th Jun 20189:05 amRNSSecond Price Monitoring Extn
19th Jun 20189:00 amRNSPrice Monitoring Extension
18th Jun 20187:00 amRNSPositive Results for Phase IIb FLU-v Field Study
23rd May 201812:30 pmRNSResult of AGM
27th Apr 20182:00 pmRNS2017 Annual Report and Financial Statements
19th Apr 20187:01 amRNSAudited 2017 Preliminary Results
19th Apr 20187:00 amRNSChief Executive Officer Steps Down
10th Apr 20187:00 amRNSStatement regarding share price
6th Apr 20187:00 amRNSNotice of Preliminary Results
5th Apr 201812:00 pmRNSDirectors' Dealings
26th Mar 20187:00 amRNSInitial results from a Phase IIb study of FLU-v
16th Jan 20187:00 amRNSAward of Share Options
9th Jan 20187:00 amRNSDirectors' Dealings
21st Dec 20177:00 amRNSAward of Share Options
14th Dec 20172:00 pmRNSDirector's Dealings
30th Oct 20177:00 amRNSDirectorate Change
5th Oct 20177:00 amRNSDirectors' Dealings
21st Sep 20177:00 amRNSHalf-year Report
10th Jul 20177:00 amRNSDirectors' Dealings
20th Jun 20177:00 amRNSBoard Change
24th May 20172:00 pmRNSResult of Annual General Meeting
18th May 20177:00 amRNSAward of Deferred Bonus Share Options
28th Apr 20172:00 pmRNS2016 Annual Report and Financial Statements
20th Apr 20177:00 amRNSAudited 2016 Preliminary Results
13th Apr 20177:00 amRNSTrading Update
5th Apr 20177:00 amRNSDirectors' Dealings
21st Feb 20174:30 pmRNSInitiation of a Phase I clinical trial with AGS-v

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.